nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.02.2015 | Neuro-Oncology (LE Abrey, Section Editor)

The Value of Extent of Resection of Glioblastomas: Clinical Evidence and Current Approach

verfasst von: Joao Paulo Almeida, Kaisorn L. Chaichana, Jordina Rincon-Torroella, Alfredo Quinones-Hinojosa

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Glioblastomas (GBM), one of the most common tumors of the central nervous system, are associated with poor prognosis, even with all the scientific development of the last decades. Individual survival, however, is not homogenous among GBM patients, and multiple factors are related to their outcome, including age, biological characteristics of the tumor, and extent of treatment. Extent of resection (EOR) plays a major role as an independent modifiable factor associated with improved overall and progression-free survival. Achievement of maximal safe resection, removing as much as possible the tumor while preserving the neurological function, is the main goal of the current surgical treatment of GBM. To reach this objective, different technologies and surgical techniques have been introduced in neuro-oncology surgery, including functional neuronavigation systems, ultrasound surgery, intraoperative MRI scan, and intraoperative cortical and subcortical mapping techniques. In the current manuscript, we examine the impact of EOR on the prognosis of GBM patients and the benefits and limitations of modern adjuvant techniques used for resection of these lesions.

Ostrom QT et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 2013;15 Suppl 2:ii1–56.PubMedCentralPubMed

Lacroix M et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190–8.PubMed

Chaichana KL et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol. 2011;18(1):239–45.PubMed

4.•

Chaichana KL et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol. 2014;16(1):113–22. Retrospective study evaluating the impact of EOR according to volumetric analyzes on the survival of GBM patients This study observed that extent of resection and residual tumor volume were significantly associated with survival, where the thresholds are 70% and 5 cm3, respectively.PubMedCentralPubMed

5.•

Sanai N et al. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3–8. Clinical study based on volumetric analyzes of EOR of glioblastoma. The authors demonstrate a stepwise improvement in survival associated with higher EOR rates. Significant survival advantage was associated with subtotal resection as low as 78 %.PubMed

Stummer W et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401.PubMed

Chaichana K et al. A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg. 2010;112(5):997–1004.PubMed

DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114–23.PubMed

Leibetseder A et al. Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO). Neuro Oncol. 2013;15(1):112–21.PubMedCentralPubMed

10.

Juratli TA et al. The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. J Neurooncol. 2012;110(3):325–33.PubMed

11.

Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6(3):227–35.PubMedCentralPubMed

12.

Stupp R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.PubMed

13.

Chaichana KL et al. When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg. 2014;82(1–2):e257–65.PubMed

14.

Chaichana KL et al. Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci. 2013;20(10):1422–6.PubMedCentralPubMed

15.

Laws ER et al. Surgical management of intracranial gliomas—does radical resection improve outcome? Acta Neurochir Suppl. 2003;85:47–53.PubMed

16.

McGirt MJ et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1):156–62.PubMed

17.

Pichlmeier U et al. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008;10(6):1025–34.PubMedCentralPubMed

18.

Sanai N, Berger MS. Extent of resection influences outcomes for patients with gliomas. Rev Neurol (Paris). 2011;167(10):648–54.

19.

Ushio Y et al. Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir (Tokyo). 2005;45(9):454–60. discussion 460–1.

20.

McGirt MJ et al. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery. 2009;65(3):463–9. discussion 469–70.PubMed

21.

Vecht CJ et al. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry. 1990;53(6):466–71.PubMedCentralPubMed

22.

Shibamoto Y et al. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol. 1990;18(1):9–17.PubMed

23.

Simpson JR et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26(2):239–44.PubMed

24.

Dinapoli RP et al. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol. 1993;11(7):1316–21.PubMed

25.

Jeremic B et al. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol. 1994;21(2):177–85.PubMed

26.

Huber A et al. Supratentorial glioma: analysis of clinical and temporal parameters in 163 cases. Neurochirurgia (Stuttg). 1993;36(6):189–93.

27.

Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer. 1995;75(11):2727–31.PubMed

28.

Barker 2nd FG et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 1996;84(3):442–8.PubMed

29.

Buckner JC et al. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer. 2001;92(2):420–33.PubMed

30.

Brown PD et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76(3):283–91.PubMed

31.

Stark AM et al. Glioblastoma multiforme—report of 267 cases treated at a single institution. Surg Neurol. 2005;63(2):162–9. discussion 169.PubMed

32.

McGirt MJ, Gokaslan ZL, Chaichana KL. Preoperative grading scale to predict survival in patients undergoing resection of malignant primary osseous spinal neoplasms. Spine J. 2011;11(3):190–6.PubMed

33.

Oszvald A et al. Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. J Neurosurg. 2012;116(2):357–64.PubMed

34.

Hollerhage HG et al. Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir (Wien). 1991;113(1–2):31–7.

35.

Phillips TL et al. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Int J Radiat Oncol Biol Phys. 1991;21(3):709–14.PubMed

36.

Duncan GG et al. The treatment of adult supratentorial high grade astrocytomas. J Neurooncol. 1992;13(1):63–72.PubMed

37.

Kowalczuk A et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1997;41(5):1028–36. discussion 1036–8.PubMed

38.

Sandberg-Wollheim M et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer. 1991;68(1):22–9.PubMed

39.•

Orringer D et al. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg. 2012;117(5):851–9. Retrospective study evaluating the impact of EOR according to volumetric analyzes on the survival of GBM patients. Significant survival advantage associated with an EOR of 90 % or more. It also shows the limitations of the surgeon’s intraoperative assessment of the EOR when compared to postop MRI scan.PubMed

40.•

Grabowski MM et al. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg. 2014;121(5):1115–23. Retrospective study evaluating the impact of EOR according to volumetric analyzes on the survival of GBM patients. This study suggests that residual tumor volume is the most significant radiological predictor of survival in glioblastoma patients.

41.

Gonzalez-Darder JM et al. Multimodal navigation in the functional microsurgical resection of intrinsic brain tumors located in eloquent motor areas: role of tractography. Neurosurg Focus. 2010;28(2):E5.PubMed

42.

Berntsen EM et al. Functional magnetic resonance imaging and diffusion tensor tractography incorporated into an intraoperative 3-dimensional ultrasound-based neuronavigation system: impact on therapeutic strategies, extent of resection, and clinical outcome. Neurosurgery. 2010;67(2):251–64.PubMed

43.

Yu CS et al. Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment. Eur J Radiol. 2005;56(2):197–204.PubMed

44.

Romano A et al. Role of magnetic resonance tractography in the preoperative planning and intraoperative assessment of patients with intra-axial brain tumours. Radiol Med. 2007;112(6):906–20.PubMed

45.

Kumar A et al. The role of neuronavigation-guided functional MRI and diffusion tensor tractography along with cortical stimulation in patients with eloquent cortex lesions. Br J Neurosurg. 2014;28(2):226–33.PubMed

46.

Mandelli ML et al. Quantifying accuracy and precision of diffusion MR tractography of the corticospinal tract in brain tumors. J Neurosurg. 2014;121(2):349–58.

47.

Wu JS et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery. 2007;61(5):935–48. discussion 948–9.PubMed

48.

Barone DG, Lawrie TA, Hart MG. Image guided surgery for the resection of brain tumours. Cochrane Database Syst Rev. 2014;1, CD009685.PubMed

49.

Berman JI et al. Accuracy of diffusion tensor magnetic resonance imaging tractography assessed using intraoperative subcortical stimulation mapping and magnetic source imaging. J Neurosurg. 2007;107(3):488–94.PubMed

50.

Berman JI et al. Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg. 2004;101(1):66–72.PubMed

51.

Makuuchi M, Torzilli G, Machi J. History of intraoperative ultrasound. Ultrasound Med Biol. 1998;24(9):1229–42.PubMed

52.

Le Roux PD et al. Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies. J Neurooncol. 1992;13(2):189–98.PubMed

53.

Dohrmann GJ, Rubin JM. History of intraoperative ultrasound in neurosurgery. Neurosurg Clin N Am. 2001;12(1):155–66. ix.PubMed

54.•

Moiyadi AV et al. Usefulness of three-dimensional navigable intraoperative ultrasound in resection of brain tumors with a special emphasis on malignant gliomas. Acta Neurochir (Wien). 2013;155(12):2217–25. Large clinical series demonstrating the impact of ultrasound-guided surgery. In this study the use of the intraoperative imaging prompted further resection in 59 % cases. In the malignant gliomas (51 cases), gross-total resection was achieved in 47 % cases, increasing to 88 % in the “resectable” subgroup.

55.

Moiyadi A, Shetty P. Objective assessment of utility of intraoperative ultrasound in resection of central nervous system tumors: a cost-effective tool for intraoperative navigation in neurosurgery. J Neurosci Rural Pract. 2011;2(1):4–11.PubMedCentralPubMed

56.

Unsgaard G et al. Brain operations guided by real-time two-dimensional ultrasound: new possibilities as a result of improved image quality. Neurosurgery. 2002;51(2):402–11. discussion 411–2.PubMed

57.

Unsgaard G et al. Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery. 2002;50(4):804–12. discussion 812.PubMed

58.

Padayachy LC, Fieggen G. Intraoperative ultrasound-guidance in neurosurgery. World Neurosurg. 2013;82(3–4):e409–11.PubMed

59.

Hervey-Jumper SL, Berger MS. Role of surgical resection in low- and high-grade gliomas. Curr Treat Options Neurol. 2014;16(4):284.PubMed

60.

Unsgaard G et al. Intra-operative 3D ultrasound in neurosurgery. Acta Neurochir (Wien). 2006;148(3):235–53. discussion 253.

61.

Solheim O et al. Ultrasound-guided operations in unselected high-grade gliomas—overall results, impact of image quality and patient selection. Acta Neurochir (Wien). 2010;152(11):1873–86.

62.

Saether CA et al. Did survival improve after the implementation of intraoperative neuronavigation and 3D ultrasound in glioblastoma surgery? A retrospective analysis of 192 primary operations. J Neurol Surg A Cent Eur Neurosurg. 2012;73(2):73–8.PubMed

63.

Black PM et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery. 1997;41(4):831–42. discussion 842–5.PubMed

64.

Kubben PL et al. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol. 2011;12(11):1062–70.PubMed

65.

Knauth M et al. Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol. 1999;20(9):1642–6.PubMed

66.

Wirtz CR et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery. 2000;46(5):1112–20. discussion 1120–2.PubMed

67.

Bohinski RJ et al. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery. 2001;49(5):1133–43. discussion 1143–4.PubMed

68.

Nimsky C et al. Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl. 2003;85:55–63.PubMed

69.

Hirschberg H et al. Impact of intraoperative MRI on the surgical results for high-grade gliomas. Minim Invasive Neurosurg. 2005;48(2):77–84.PubMed

70.

Schneider JP et al. Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme—a quantitative radiological analysis. Neuroradiology. 2005;47(7):489–500.PubMed

71.

Muragaki Y et al. Usefulness of intraoperative magnetic resonance imaging for glioma surgery. Acta Neurochir Suppl. 2006;98:67–75.PubMed

72.

Busse H et al. Advanced approach for intraoperative MRI guidance and potential benefit for neurosurgical applications. J Magn Reson Imaging. 2006;24(1):140–51.PubMed

73.

Nimsky C et al. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res. 2006;28(5):482–7.PubMed

74.

Hatiboglu MA et al. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery. 2009;64(6):1073–81. discussion 1081.PubMed

75.

Lenaburg HJ, Inkabi KE, Vitaz TW. The use of intraoperative MRI for the treatment of glioblastoma multiforme. Technol Cancer Res Treat. 2009;8(2):159–62.PubMed

76.

Senft C et al. Low field intraoperative MRI-guided surgery of gliomas: a single center experience. Clin Neurol Neurosurg. 2010;112(3):237–43.PubMed

77.•

Senft C et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12(11):997–1003. Randomized controlled trial demonstrating the benefits of intraoperative MRI to achieve large resections of glioblastomas. The authors show that more patients in the intraoperative MRI group had complete tumor resection (23 [96 %] of 24 patients) than did in the control group (17 [68 %] of 25, p = 0 · 023).PubMed

78.

Foroglou N, Zamani A, Black P. Intra-operative MRI (iop-MR) for brain tumour surgery. Br J Neurosurg. 2009;23(1):14–22.PubMed

79.

Alexander 3rd E et al. The present and future role of intraoperative MRI in neurosurgical procedures. Stereotact Funct Neurosurg. 1997;68(1–4 Pt 1):10–7.PubMed

80.

Gerlach R et al. Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery. 2008;63(2):272–84. discussion 284–5.PubMed

81.

D’Amico RS, Kennedy BC, Bruce JN. Neurosurgical oncology: advances in operative technologies and adjuncts. J Neurooncol. 2014;119(3):451–63.PubMed

82.

Albert FK et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34(1):45–60. discussion 60–1.PubMed

83.

Zhao S et al. Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS ONE. 2013;8(5):e63682.PubMedCentralPubMed

84.

Regula J et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX—a pilot study. Gut. 1995;36(1):67–75.PubMedCentralPubMed

85.

Kennedy AS. Radiation oncology approaches in liver malignancies. Am Soc Clin Oncol Educ Book. 2014;e150-e155. doi: 10.14694/EdBook_AM.2014.34.e150.

86.

el-Sharabasy MM et al. Porphyrin metabolism in some malignant diseases. Br J Cancer. 1992;65(3):409–12.PubMedCentralPubMed

87.

Pottier RH et al. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol. 1986;44(5):679–87.PubMed

88.

Roberts DW et al. Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid). Neurosurg Clin N Am. 2012;23(3):371–7.PubMedCentralPubMed

89.

Stummer W et al. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien). 1998;140(10):995–1000.

90.

Duffner F et al. Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol. 2005;71(2):107–11.PubMed

91.

Stummer W et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003–13.PubMed

92.

Lilge L et al. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br J Cancer. 1996;73(3):332–43.PubMedCentralPubMed

93.

Diez Valle R et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol. 2011;102(1):105–13.PubMed

94.

Schucht P et al. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir (Wien). 2014;156(2):305–12. discussion 312.

95.

Stummer W et al. 5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. Neurosurgery. 2014;74(3):310–9. discussion 319–20.PubMedCentralPubMed

96.

Li Y et al. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. World Neurosurg. 2014;82(1–2):175–85.

97.

Miyatake S et al. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report. Neurosurgery. 2007;61(5):E1101–3. discussion E1103-4.PubMed

98.

Rasmussen T, Penfield W. Further studies of the sensory and motor cerebral cortex of man. Fed Proc. 1947;6(2):452–60.PubMed

99.

Schucht P et al. Subcortical electrostimulation to identify network subserving motor control. Hum Brain Mapp. 2013;34(11):3023–30.PubMed

100.

Duffau H. Acute functional reorganisation of the human motor cortex during resection of central lesions: a study using intraoperative brain mapping. J Neurol Neurosurg Psychiatry. 2001;70(4):506–13.PubMedCentralPubMed

101.

Fontaine D, Capelle L, Duffau H. Somatotopy of the supplementary motor area: evidence from correlation of the extent of surgical resection with the clinical patterns of deficit. Neurosurgery. 2002;50(2):297–303. discussion 303–5.PubMed

102.

Ranck Jr JB. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 1975;98(3):417–40.PubMed

103.

Sanai N, Berger MS. Intraoperative stimulation techniques for functional pathway preservation and glioma resection. Neurosurg Focus. 2010;28(2):E1.PubMed

104.

Duffau H. A new philosophy in surgery for diffuse low-grade glioma (DLGG): oncological and functional outcomes. Neurochirurgie. 2013;59(1):2–8.PubMed

105.

Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. N Engl J Med. 2008;358(1):18–27.PubMed

106.

Sanai N, Berger MS. Mapping the horizon: techniques to optimize tumor resection before and during surgery. Clin Neurosurg. 2008;55:14–9.PubMed

107.

De Witt Hamer PC et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol. 2012;30(20):2559–65.PubMed

Titel: The Value of Extent of Resection of Glioblastomas: Clinical Evidence and Current Approach
verfasst von: Joao Paulo Almeida
Kaisorn L. Chaichana
Jordina Rincon-Torroella
Alfredo Quinones-Hinojosa
Publikationsdatum: 01.02.2015
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 2/2015
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-014-0517-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Rescue Therapy for Refractory Vasospasm after Subarachnoid Hemorrhage

Applications of Neuroscience in Criminal Law: Legal and Methodological Issues

Does Aerobic Exercise and the FITT Principle Fit into Stroke Recovery?

Diagnosis and Treatment of Chorea Syndromes

Tension-Type Headache and Sleep